BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2018
View Archived Issues
Sigilon Therapeutics' SIG-003 awarded EMA ATMP designation
Read More
iOx Therapeutics receives investment from Portage Biotech
Read More
Novel algorithm using proteotoxic biomarkers to discriminate between ASD and healthy subjects
Read More
Phase II data presented from the STOP-AKI trial of recAP in sepsis-associated acute kidney injury
Read More
Solifenacin oral suspension for pediatric patients approved in Europe
Read More
First-in-human results for Progenza in patients with knee osteoarthritis
Read More
Polyphor reports outcome of end-of-phase I meeting with FDA on balixafortide
Read More
Aradigm submits MAA for Linhaliq in non-cystic fibrosis bronchiectasis
Read More
CHRIST University patents new ER-targeting conjugates for cancer
Read More
Nanchang Helioeast Pharmaceutical presents new TKIs for cancer
Read More
Voyager Therapeutics reports longer-term data from phase Ib study of VY-AADC in Parkinson's disease
Read More
Biohaven restructures license agreement with Bristol-Myers Squibb
Read More
Medivir discloses novel compounds for RSV infection
Read More
IO Biotech collaborates with Merck & Co. to study IO-102 with pembrolizumab for NSCLC
Read More
Deinove enters antibiotic research collaboration with Naicons
Read More
FDA grants regenerative medicine advanced therapy designation to AmnioFix
Read More
BC-007 reduces autoantibodies against G-protein coupled receptors in phase I study
Read More
Seattle Genetics' acquisition of Cascadian Therapeutics complete
Read More
Kezar Life Sciences initiates phase I/II study of KZR-616 in SLE
Read More
Arrowhead opens enrollment in phase I study of ARO-AAT
Read More
Immutep and Merck & Co. to collaborate on phase II study of eftilagimod with pembrolizumab
Read More
CSL-112 found safe in patients with renal impairment after AMI
Read More
Diamyd Medical offers update from DIAGNODE-1 study of Diamyd diabetes vaccine
Read More
FDA awards fast track designation to NovaBiotics' Lynovex
Read More
Atrial fibrillation burden not reduced by XEN-D0103 in patients with pacemakers
Read More